Answers are grounded in this paper and cite their sources.
Randomized clinical trials have reported some safety profiles in inclisiran, but adverse events in real-world remain insufficient. We aim to evaluate the safety of inclisiran in real-world by collecting the data from the FDA Adverse Event Reporting System database.
No takes yet. Share an insight, caveat, or question.
Cai et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: